1. Market Research
  2. > Biotechnology Market Trends
  3. > Biopharmaceutical

Breakthroughs that will shape the future of the targeted therapy market

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
9 votes

Global Biopharmaceutical Industry

The global biopharmaceutical industry (a part of the biotechnology market) is currently worth over $145 billion, according to research conducted by BioPlan Associates. The industry should exceed $167 billion in 2015, says IMARC. 

Biopharmaceuticals are used in the prevention and treatment of disease, and there are over 300 approved biopharmaceuticals on the market, with many in clinical development yet to come. The market has benefited from the need for pharmaceutical manufacturers to boost output, but it has a high risk factor, with only three out of 10 drugs that pass to the clinical phase receiving market clearance.

Cost containment and biosimilar entry in developed markets continue to see slow growth, but the market should expand thanks to biopharmaceutical capacity to outperform traditional small molecule drugs. Over the coming five-year period, factors such as development of emerging markets and a rich late-stage pipeline are expected to fuel growth.

Key Market Segments

The world biosimilar market is expected to record yearly growth in excess of 50% between 2010 and 2015, reports RNCOS. Market growth is being driven by factors such as costly drugs, high pharmaceutical expenditure and a global aging population. Market expansion will be further fuelled by expiring patents and the increasing cost of drugs. Sandoz is the leading company operating in the global biosimilars market, recording the highest sales. Teva and Hospira are developing a biosimilar product range.

The global enzyme market is expected to exceed $7.5 billion in 2015, reports Freedonia, and it should surpass yearly growth of 5%. The fastest rate of growth will be recorded in smaller markets such as the Africa/Middle East region, and Central and South America. Asia-Pacific is expected to record strong growth, while the EU and North America are forecast to record below-average growth.

The global protein therapeutics market is forecast to see yearly growth of 13% between 2012 and 2014, reports RNCOS. Increased investment and the introduction of new protein therapeutics will fuel market  expansion. Protein therapeutics have been recording a high rate of growth in recent years, vital to the treatment of many diseases. Protein therapeutics are particularly efficient due to their targeted approach, which allows the treatment of disease with little or no negative impact on healthy organs. Protein therapies are necessary in a healthcare landscape, witnessing rapidly rising rates of chronic illnesses like cardiovascular diseases, diabetes and cancer.

The cancer monoclonal antibodies market is expected to grow at a yearly rate in excess of 5% between 2012 and 2015, according to RNCOS. Cancer monoclonal antibodies are used to treat tumors with a high degree of specification. The market is driven by increasing prevalence of cancer and the need for more innovation research. The industry is witnessing rising consolidation.

Read more »

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+44 20 8816 8032

1-10 of about 4 100 reports

Global Biopharmaceutical Industry

  • January 2015
    72 pages
  • Biopharmaceutic  

  • United States  

    World  

    Europe  

View report >

Biopharmaceutical Industry in the US

  • November 2015
    12 pages
  • Biopharmaceutic  

  • United States  

View report >

Biopharmaceutical Supply in the US and Japan

  • June 2015
    11 pages
  • Biopharmaceutic  

  • United States  

    Japan  

View report >

Biopharmaceutical Industry in France

  • January 2014
    14 pages
  • Biopharmaceutic  

  • France  

View report >

Biopharmaceutical Industry in Germany and the US

  • July 2015
    14 pages
  • Biopharmaceutic  

  • Germany  

    United States  

View report >

Biopharmaceutical Industry in Italy

  • January 2015
    11 pages
  • Biopharmaceutic  

  • Italy  

View report >

Biopharmaceutical Industry in the UK

  • November 2015
    9 pages
  • Biopharmaceutic  

  • United Kingdom  

View report >

Biopharmaceutical Markets in Canada Forecast

  • November 2015
    16 pages
  • Biopharmaceutic  

  • Canada  

View report >

Biopharmaceutical Industry in Brazil

  • January 2015
    5 pages
  • Biopharmaceutic  

  • Brazil  

View report >

Search in Biopharmaceutical Industry (About 4 100 reports)
Parent industry: Biotechnology
Related industries: Biological Therapy, Biomaterial, Genetically Modified Organism, Genomics

About 2 700 reports

Purchase Reports From Reputable Market Research Publishers
(From € 79 - € 6 316)

Testing and Analysis Services Market: (By Sample Type: Water, Soil/Sediment, Clay Mineral, Metal Alloy, Biological Sample, Food, Chemicals, Corrosion, Oil and Gas, and Minerals and Ores; By Analysis Type: Elemental, Organic, Isotopic, Particle Size, Miner

Testing and Analysis Services Market: (By Sample Type: Water, Soil/Sediment, Clay Mineral, Metal Alloy, Biological Sample, Food, Chemicals, Corrosion, Oil and Gas, and Minerals and Ores; By Analysis Type: Elemental, Organic, Isotopic, Particle Size, Miner

  • € 6 316
  • Industry report
  • November 2015
  • by Transparency Market Research

This report on the testing and analysis services market studies the current as well as future prospects of the market. The stakeholders of this report include testing and analysis companies catering to ...

Frontier Pharma: Ovarian Cancer - Identifying And Comme ...

December 2015 € 5 596

Whey Protein Products: Global Markets

January 2016 € 5 320

Erythropoietin Stimulating Agents: Therapeutic Applicat ...

January 2016 € 5 320

Marketview: Shigella Vaccines

January 2016 € 4 375

Breast Cancer Therapeutics In Major Developed Markets T ...

December 2015 € 3 996

Global Immunology Market To 2022 - Large Pipeline And C ...

December 2015 € 3 996

Pancreatic Cancer Therapeutics In Major Developed Marke ...

December 2015 € 3 996

Marketview: Helicobacter Pylori Vaccines

December 2015 € 3 750

Marketview: E.coli (expec) Vaccines

December 2015 € 3 750

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.